(Q33544158)

27 July 2017

1 reference

title

Interferon-beta1A-induced polyarthritis in a patient with the HLA-DRB1*0404 allele (English)

1 reference

27 July 2017

1 reference

Levesque MC

1

1 reference

27 July 2017

Ward FE

series ordinal

2

1 reference

27 July 2017

Jeffery DR

series ordinal

3

1 reference

27 July 2017

Weinberg JB

series ordinal

4

1 reference

27 July 2017

publication date

1 March 1999

1 reference

27 July 2017

published in

Arthritis & Rheumatology

1 reference

27 July 2017

volume

42

1 reference

27 July 2017

issue

3

1 reference

27 July 2017

page(s)

569-573

1 reference

Multiple sclerosis: immune mechanism and update on current therapies

27 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199904%2942%3A3%3C569%3A%3AAID-ANR23%3E3.0.CO%3B2-M

Immune-mediated side-effects of cytokines in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199904%2942%3A3%3C569%3A%3AAID-ANR23%3E3.0.CO%3B2-M

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199904%2942%3A3%3C569%3A%3AAID-ANR23%3E3.0.CO%3B2-M

Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199904%2942%3A3%3C569%3A%3AAID-ANR23%3E3.0.CO%3B2-M

Hepatitis C virus infection and autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199904%2942%3A3%3C569%3A%3AAID-ANR23%3E3.0.CO%3B2-M

Exacerbation of symptoms of autoimmune disease in patients receiving alpha-interferon therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199904%2942%3A3%3C569%3A%3AAID-ANR23%3E3.0.CO%3B2-M

Mono-arthritis in a chronic hepatitis B patient after alpha-interferon treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199904%2942%3A3%3C569%3A%3AAID-ANR23%3E3.0.CO%3B2-M

Rheumatoid Arthritis-like Disease after Alpha-Interferon Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199904%2942%3A3%3C569%3A%3AAID-ANR23%3E3.0.CO%3B2-M

A case of arthropathy and hypothyroidism during recombinant alpha-interferon therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199904%2942%3A3%3C569%3A%3AAID-ANR23%3E3.0.CO%3B2-M

Pathogenesis of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199904%2942%3A3%3C569%3A%3AAID-ANR23%3E3.0.CO%3B2-M

Correlation between disease phenotype and genetic heterogeneity in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199904%2942%3A3%3C569%3A%3AAID-ANR23%3E3.0.CO%3B2-M

Increased expression of blood mononuclear cell nitric oxide synthase type 2 in rheumatoid arthritis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199904%2942%3A3%3C569%3A%3AAID-ANR23%3E3.0.CO%3B2-M

Nitric oxide: a novel mediator of inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199904%2942%3A3%3C569%3A%3AAID-ANR23%3E3.0.CO%3B2-M

Interferon (IFN)-alpha activation of human blood mononuclear cells in vitro and in vivo for nitric oxide synthase (NOS) type 2 mRNA and protein expression: possible relationship of induced NOS2 to the anti-hepatitis C effects of IFN-alpha in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199904%2942%3A3%3C569%3A%3AAID-ANR23%3E3.0.CO%3B2-M

10.1002/1529-0131(199904)42:3<569::AID-ANR23>3.0.CO;2-M

21 January 2018

Identifiers

DOI

1 reference

27 July 2017

1 reference